Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC33543100852;100853;100854 chr2:178536120;178536119;178536118chr2:179400847;179400846;179400845
N2AB3190295929;95930;95931 chr2:178536120;178536119;178536118chr2:179400847;179400846;179400845
N2A3097593148;93149;93150 chr2:178536120;178536119;178536118chr2:179400847;179400846;179400845
N2B2447873657;73658;73659 chr2:178536120;178536119;178536118chr2:179400847;179400846;179400845
Novex-12460374032;74033;74034 chr2:178536120;178536119;178536118chr2:179400847;179400846;179400845
Novex-22467074233;74234;74235 chr2:178536120;178536119;178536118chr2:179400847;179400846;179400845
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: Y
  • RefSeq wild type transcript codon: TAT
  • RefSeq wild type template codon: ATA
  • Domain: Ig-158
  • Domain position: 48
  • Structural Position: 121
  • Q(SASA): 0.1797
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
Y/H None None 0.994 D 0.528 0.451 0.488477830397 gnomAD-4.0.0 1.5917E-06 None None None None N None 0 0 None 0 0 None 0 0 2.85896E-06 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
Y/A 0.8592 likely_pathogenic 0.8919 pathogenic -2.984 Highly Destabilizing 0.747 D 0.405 neutral None None None None N
Y/C 0.2691 likely_benign 0.3225 benign -1.979 Destabilizing 0.998 D 0.546 neutral N 0.508511207 None None N
Y/D 0.9008 likely_pathogenic 0.8978 pathogenic -3.096 Highly Destabilizing 0.993 D 0.593 neutral D 0.535516232 None None N
Y/E 0.9408 likely_pathogenic 0.9429 pathogenic -2.915 Highly Destabilizing 0.985 D 0.517 neutral None None None None N
Y/F 0.118 likely_benign 0.1545 benign -1.111 Destabilizing 0.549 D 0.447 neutral N 0.495021231 None None N
Y/G 0.8542 likely_pathogenic 0.8519 pathogenic -3.404 Highly Destabilizing 0.985 D 0.543 neutral None None None None N
Y/H 0.5219 ambiguous 0.5535 ambiguous -1.964 Destabilizing 0.994 D 0.528 neutral D 0.528557801 None None N
Y/I 0.4131 ambiguous 0.5509 ambiguous -1.613 Destabilizing 0.001 N 0.235 neutral None None None None N
Y/K 0.9331 likely_pathogenic 0.9286 pathogenic -2.255 Highly Destabilizing 0.889 D 0.528 neutral None None None None N
Y/L 0.5271 ambiguous 0.6222 pathogenic -1.613 Destabilizing 0.047 N 0.327 neutral None None None None N
Y/M 0.6851 likely_pathogenic 0.781 pathogenic -1.38 Destabilizing 0.972 D 0.527 neutral None None None None N
Y/N 0.5884 likely_pathogenic 0.6078 pathogenic -2.977 Highly Destabilizing 0.998 D 0.572 neutral N 0.505802182 None None N
Y/P 0.9807 likely_pathogenic 0.9832 pathogenic -2.081 Highly Destabilizing 0.999 D 0.59 neutral None None None None N
Y/Q 0.8916 likely_pathogenic 0.8967 pathogenic -2.748 Highly Destabilizing 0.995 D 0.541 neutral None None None None N
Y/R 0.888 likely_pathogenic 0.8722 pathogenic -1.946 Destabilizing 0.99 D 0.568 neutral None None None None N
Y/S 0.7295 likely_pathogenic 0.7574 pathogenic -3.379 Highly Destabilizing 0.98 D 0.498 neutral D 0.533118259 None None N
Y/T 0.7312 likely_pathogenic 0.7838 pathogenic -3.076 Highly Destabilizing 0.931 D 0.44 neutral None None None None N
Y/V 0.3448 ambiguous 0.4624 ambiguous -2.081 Highly Destabilizing 0.014 N 0.234 neutral None None None None N
Y/W 0.5821 likely_pathogenic 0.6027 pathogenic -0.541 Destabilizing 0.997 D 0.533 neutral None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.